130 related articles for article (PubMed ID: 20437433)
1. Identification and structure of small-molecule stabilizers of 14-3-3 protein-protein interactions.
Rose R; Erdmann S; Bovens S; Wolf A; Rose M; Hennig S; Waldmann H; Ottmann C
Angew Chem Int Ed Engl; 2010 Jun; 49(24):4129-32. PubMed ID: 20437433
[No Abstract] [Full Text] [Related]
2. Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions.
Geppert T; Bauer S; Hiss JA; Conrad E; Reutlinger M; Schneider P; Weisel M; Pfeiffer B; Altmann KH; Waibler Z; Schneider G
Angew Chem Int Ed Engl; 2012 Jan; 51(1):258-61. PubMed ID: 22095772
[No Abstract] [Full Text] [Related]
3. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
Block P; Weskamp N; Wolf A; Klebe G
Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
[TBL] [Abstract][Full Text] [Related]
4. X-ray structure of domain I of the proton-pumping membrane protein transhydrogenase from Escherichia coli.
Johansson T; Oswald C; Pedersen A; Törnroth S; Okvist M; Karlsson BG; Rydström J; Krengel U
J Mol Biol; 2005 Sep; 352(2):299-312. PubMed ID: 16083909
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 protein interacts with and affects the structure of RGS domain of regulator of G protein signaling 3 (RGS3).
Rezabkova L; Boura E; Herman P; Vecer J; Bourova L; Sulc M; Svoboda P; Obsilova V; Obsil T
J Struct Biol; 2010 Jun; 170(3):451-61. PubMed ID: 20347994
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of cooperative ligand binding in the adaptive region of interleukin-2.
Hyde J; Braisted AC; Randal M; Arkin MR
Biochemistry; 2003 Jun; 42(21):6475-83. PubMed ID: 12767230
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a proton pumping transmembrane protein incorporated into a supported three-dimensional matrix of proteoliposomes.
Granéli A; Benkoski JJ; Höök F
Anal Biochem; 2007 Aug; 367(1):87-94. PubMed ID: 17524345
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure and site 1 binding energetics of human placental lactogen.
Walsh ST; Kossiakoff AA
J Mol Biol; 2006 May; 358(3):773-84. PubMed ID: 16546209
[TBL] [Abstract][Full Text] [Related]
9. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
Covaceuszach S; Cattaneo A; Lamba D
Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
[TBL] [Abstract][Full Text] [Related]
12. Analysis of protein-DNA interactions using surface plasmon resonance.
Majka J; Speck C
Adv Biochem Eng Biotechnol; 2007; 104():13-36. PubMed ID: 17290817
[TBL] [Abstract][Full Text] [Related]
13. Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with monoaryl P4 motifs.
Kleanthous S; Borthwick AD; Brown D; Burns-Kurtis CL; Campbell M; Chaudry L; Chan C; Clarte MO; Convery MA; Harling JD; Hortense E; Irving WR; Irvine S; Pateman AJ; Patikis AN; Pinto IL; Pollard DR; Roethka TJ; Senger S; Shah GP; Stelman GJ; Toomey JR; Watson NS; West RI; Whittaker C; Zhou P; Young RJ
Bioorg Med Chem Lett; 2010 Jan; 20(2):618-22. PubMed ID: 20006499
[TBL] [Abstract][Full Text] [Related]
14. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
Kenward AG; Bartolotti LJ; Burns CS
Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
[TBL] [Abstract][Full Text] [Related]
15. Structural and biophysical characterization of XIAP BIR3 G306E mutant: insights in protein dynamics and application for fragment-based drug design.
Moore CD; Wu H; Bolaños B; Bergqvist S; Brooun A; Pauly T; Nowlin D
Chem Biol Drug Des; 2009 Sep; 74(3):212-23. PubMed ID: 19660030
[TBL] [Abstract][Full Text] [Related]
16. Organization of functional domains in the docking protein p130Cas.
Nasertorabi F; Garcia-Guzman M; Briknarová K; Larsen E; Havert ML; Vuori K; Ely KR
Biochem Biophys Res Commun; 2004 Nov; 324(3):993-8. PubMed ID: 15485652
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel protein kinase B inhibitor by structure-based virtual screening.
Medina-Franco JL; Giulianotti MA; Yu Y; Shen L; Yao L; Singh N
Bioorg Med Chem Lett; 2009 Aug; 19(16):4634-8. PubMed ID: 19604696
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the plasma membrane proton pump.
Pedersen BP; Buch-Pedersen MJ; Morth JP; Palmgren MG; Nissen P
Nature; 2007 Dec; 450(7172):1111-4. PubMed ID: 18075595
[TBL] [Abstract][Full Text] [Related]
19. Binding site detection and druggability index from first principles.
Seco J; Luque FJ; Barril X
J Med Chem; 2009 Apr; 52(8):2363-71. PubMed ID: 19296650
[TBL] [Abstract][Full Text] [Related]
20. Structural alterations for proton translocation in the M state of wild-type bacteriorhodopsin.
Sass HJ; Büldt G; Gessenich R; Hehn D; Neff D; Schlesinger R; Berendzen J; Ormos P
Nature; 2000 Aug; 406(6796):649-53. PubMed ID: 10949308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
